Racmose Pharmaceuticals Private Limited
About Racmose Pharmaceuticals Private Limited
Data last updated:
Racmose Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 11 August 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85121DL2006PTC151955. Its GSTIN is 07AADCR3577P1ZP (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sachin Suri and Shiv Kumar Suri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 22 Prashant Vihar, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.55 Lakh, a decline of 15% compared to the previous year. For the same year it recorded a net loss of ₹2.04 Lakh (net margin -12.3%) and EBITDA of -₹1.57 Lakh (EBITDA margin -9.5%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years and 5% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Racmose Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 22 Prashant Vihar, Delhi, India – 110085
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Racmose Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Racmose Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Racmose Pharmaceuticals Private Limited, buy the company report.
Financials of Racmose Pharmaceuticals Private Limited
FY 2025 filings availableRacmose Pharmaceuticals Private Limited reported revenue of ₹16.55 Lakh (down 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 15% fall in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.57 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.04 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -9.5% | ||||
| Net Profit Margin | -12.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Racmose Pharmaceuticals Private Limited, buy the company report.
Board of directors of Racmose Pharmaceuticals Private Limited
Racmose Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Suri | Director | 11 Aug 2006 | 20 Years 2 Months | Current |
| Shiv Kumar Suri | Director | 14 Jun 2008 | 18 Years 4 Months | Current |
Auditor
Racmose Pharmaceuticals Private Limited is audited by APV & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| APV & ASSOCIATES | FY 2017 | 0123143W |
Shareholding
The shareholding of Racmose Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Racmose Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Racmose Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Racmose Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Racmose Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCR3577P1ZP | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Racmose Pharmaceuticals Private Limited, buy the company report.
Recent activity
Racmose Pharmaceuticals Private Limited has 3 board changes on record since 2006: 2 appointments and 1 cessation. The latest: Urmil Suri ceased to be Director on 22 Jun 2008.
Frequently asked questions
Racmose Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 11 August 2006 (20+ years old) and is registered under CIN U85121DL2006PTC151955.
Racmose Pharmaceuticals has 2 current directors:
- Sachin Suri - Director
- Shiv Kumar Suri - Director
The latest financial statements of Racmose Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Racmose Pharmaceuticals is 07AADCR3577P1ZP, registered in Delhi.
The CIN (Corporate Identification Number) of Racmose Pharmaceuticals is U85121DL2006PTC151955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Racmose Pharmaceuticals was incorporated on 11 August 2006, making it 20+ years old. It is registered with the Registrar of Companies, Delhi.
Urmil Suri ceased to be Director on 22 Jun 2008. Shiv Kumar Suri was appointed as Director on 14 Jun 2008. Sachin Suri was appointed as Director on 11 Aug 2006.
The registered office of Racmose Pharmaceuticals is at B – 22 Prashant Vihar, Delhi, India – 110085.
Racmose Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Racmose Pharmaceuticals is compliant as of 07 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
